TAVRFinder vs COAPT Risk Score Usage & Stats
Patients want a physician who is entirely focused on the most important part of their care process - the actual procedure! If someone who has aortic valve stenosis is in need of a TAVR procedure, interventional cardiologists are suddenly hit with more work than imagined, having to do plenty of work before the procedure to ensure the proper TAVR device is chosen and eventually placed in the patient. With multiple manufacturers, and multiple sizes of TAVR device per manufacturer, the selection process is overly complex and requires the full attention of the physician to do the relevant computations. One mistake in these computations could lead to a TAVR being too small for a patient's aortic valve, and slipping out under intense flow.
Thankfully, now there is a solution to this overly complex process - TAVRFinder!
TAVRFinder is an app to help interventional cardiologists simplify their transcatheter aortic valve replacement (TAVR) workflow. Input your patient's relevant aortic valve measurements, let the app decide which TAVR devices would be the best fit, and make your selection there. If you've had a convoluted TAVR workflow with messy computations, disorganized patient records, and constant calculator use, TAVRFinder is the app for you.
Save time - TAVRFinder eliminates confusion and does the calculations for you, letting you focus on the actual procedure
Reduce error - TAVRFinder will do the math for you, and will push alerts if it detects problems with your selected TAVR device
Stay organized - TAVRFinder's easy to use UI presents your patients to you clearly, allowing you to edit patient measurements and mark procedures as complete
Ditch your old-fashioned methods and rely on TAVRFinder to do the easy work for you, so you can focus on providing the best care possible!
TAVRFinder collects NO PHI and is completely HIPAA compliant. All aortic valve measurements are stored only on the device - the app has no internet functionality. No names, or relevant patient dates are recorded.
- Apple App Store
- Free
- Medical
Store Rank
- -
For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy.
The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER.
Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.
- Apple App Store
- Free
- Medical
Store Rank
- -
TAVRFinder VS. 
COAPT Risk ScoreJanuary 15, 2026